Zenith's BET Inhibitor ZEN-3694 is Currently Being Evaluated in Multiple Oncology Clinical Trials
New SEDAR docs available.
http://www.sedar.com/DisplayCompanyDocuments.do?lang=EN&issuerNo=00034616